DRIO on Nasdaq

DarioHealth Corp.

We are a vertically integrated health intelligence platform with a mission to power the behavior changes that drive better health.3 From its latest annual report

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with Baird Medical Investment Holdings Ltd, Spectral AI, Inc. or Sonoma Pharmaceuticals, Inc., or pick any stock.

  • TickerDRIO on Nasdaq1
  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersNew York, New York1
  • Incorporated inDE2
  • Business address322 W 57Th St. #33B, New York, Ny 100192
  • Filer categoryNon-accelerated filer, Smaller reporting company2
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

We are a vertically integrated health intelligence platform with a mission to power the behavior changes that drive better health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, AI built on that proprietary data, and a behavior change and coaching layer validated through over 100 peer-reviewed clinical studies. We are committed to transforming healthcare by delivering a comprehensive and highly engaging whole-person health platform, which enables us to create a future where healthy change is effortless and accessible to all.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

56.6%Gross margin4
-163.9%Operating margin4
-186.6%Net margin4
-17.3%Revenue growth, 20254
-61.4%Return on equity4
0.45×Debt to equity4
-$26.1MFree cash flow4

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Service brought in 67% of the revenue DarioHealth Corp. broke down this way in fiscal 2025.

  1. Service$14.9M467%down 26% from 2024
  2. Hardware and Consumable Products$7.4M433%up 9% from 2024
Products and services by year
Products and services20242025
Service$20.2M$14.9M
Hardware and Consumable Products$6.8M$7.4M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue41¢$9.7M
  • Research and development58¢$13.8M
  • Income tax0¢$105.0K

Out of $22.4M in revenue.4 The company lost money this year.

Financial statements

Revenue567894$22.4M in 2025+196% since 2019
0$10.0M$20.0M$30.0M2019: $7.6M$7.6M20192020: $7.6M$7.6M2020+0%2021: $20.5M$20.5M2021+171%2022: $27.7M$27.7M2022+35%2023: $20.4M$20.4M2023−26%2024: $27.0M$27.0M2024+33%2025: $22.4M$22.4M2025−17%
Gross profit567894$12.7M in 2025+388% since 2019
0$5.0M$10.0M$15.0M2019: $2.6M$2.6M20192020: $2.5M$2.5M2020−3%2021: $4.0M$4.0M2021+58%2022: $9.7M$9.7M2022+144%2023: $6.0M$6.0M2023−38%2024: $13.3M$13.3M2024+122%2025: $12.7M$12.7M2025−5%
Operating income567894-$36.7M in 2025+107% since 2019
-$80.0M-$60.0M-$40.0M-$20.0M02019: -$17.7M-$17.7M20192020: -$29.9M-$29.9M2020+69%2021: -$76.5M-$76.5M2021+156%2022: -$56.8M-$56.8M2022−26%2023: -$56.2M-$56.2M2023−1%2024: -$57.7M-$57.7M2024+3%2025: -$36.7M-$36.7M2025−37%
Net income567894-$41.7M in 2025+135% since 2019
-$80.0M-$60.0M-$40.0M-$20.0M02019: -$17.7M-$17.7M20192020: -$29.4M-$29.4M2020+66%2021: -$76.8M-$76.8M2021+161%2022: -$62.2M-$62.2M2022−19%2023: -$59.4M-$59.4M2023−4%2024: -$42.7M-$42.7M2024−28%2025: -$41.7M-$41.7M2025−2%

Every line of the income statement as filed: the last 2 fiscal years, latest first.4

Period ending2025-12-312024-12-31
Total revenues$22.4M$27.0M
Total cost of revenues$9.7M$13.8M
Gross profit$12.7M$13.3M
Research and development$13.8M$24.2M
Sales and marketing$20.3M$26.4M
General and administrative$15.2M$20.5M
Total operating expenses$49.3M$71.0M
Operating loss$36.7M$57.7M
Interest expenses$3.0M
Other financial expenses (income), net$1.9M-$13.1M
Total financial expenses (income), net$5.0M-$13.1M
Loss before taxes$41.6M$44.6M
Income taxes (benefit)$105.0K-$1.9M
Net loss$41.7M$42.7M
Deemed dividend (contribution)$20.0M-$1.8M
Net loss attributable to common shareholders$61.7M$41.0M
Basic net loss per share of common stock (in dollars per share)$10.12$12.27
Diluted net loss per share of common stock (in dollars per share)$10.12$12.27
Weighted average number of common stock used in computing basic and diluted net loss per share4.0M shares2.5M shares
Weighted average number of common stock used in computing diluted net loss per share (in shares)4.0M shares2.5M shares

Compare DarioHealth Corp. with another company

Leadership

Who has led DarioHealth Corp., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Oren Fuerst2013
  2. Erez Raphael2016–now

President

  1. Shilo Ben-Zeev2013

Chief financial officer

  1. Mordechi Hershkowitz2013
  2. Zvi Ben-David2016–2024
  3. Chen Franco-Yehuda2025–now

Chief operating officer

  1. Shilo Ben-Zeev2013
  2. Dror Bacher2017–2022
  3. Tomer Ben-Kiki2024
  4. Lara Ann Sherman2026–now
201520202025
Board members and other officers (23)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Chief Commercial OfficerSteven Nelson named Jan 17, 2025 to Oct 7, 202541
  • Chief Executive Officer and DirectorRaphael Erez named May 16, 2023 to Feb 29, 202442
  • PresidentRichard Anderson named May 16, 2023 to Feb 29, 202442
  • DirectorJon M. Kaplan named May 16, 2023 to Jan 17, 202543
  • DirectorDennis Matthesis named May 16, 202344

Former names

  • LabStyle Innovations Corp.Nov 1, 2011 to Jul 27, 20162

Timeline

  1. Mar 3, 2016New chief executive Erez Raphael becomes CEO12
  2. Feb 19, 2013New chief executive Oren Fuerst becomes CEO13

Filings

263 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 60 major events, 76 insider forms, 35 large holders, 5 private raises, 67 other. The latest 20:

  1. Sep 28, 20264 OWNERSHIP DOCUMENT EDGAR
  2. Sep 28, 20264 OWNERSHIP DOCUMENT EDGAR
  3. Sep 28, 20264 OWNERSHIP DOCUMENT EDGAR
  4. Sep 28, 20264 OWNERSHIP DOCUMENT EDGAR
  5. Sep 28, 20264 OWNERSHIP DOCUMENT EDGAR
  6. Sep 28, 20264 OWNERSHIP DOCUMENT EDGAR
  7. Sep 28, 20264 OWNERSHIP DOCUMENT EDGAR
  8. Sep 28, 20264 OWNERSHIP DOCUMENT EDGAR
  9. Sep 28, 20263 OWNERSHIP DOCUMENT EDGAR
  10. Sep 4, 20268-K EDGAR
  11. Aug 21, 20268-K EDGAR
  12. Aug 11, 202610-Q EDGAR
  13. Jul 28, 20264 OWNERSHIP DOCUMENT EDGAR
  14. Jul 22, 20268-K EDGAR
  15. Jul 22, 2026424B5 EDGAR
  16. Jul 10, 20268-K EDGAR
  17. May 13, 202610-Q EDGAR
  18. May 7, 2026SD EDGAR
  19. Apr 13, 20263 OWNERSHIP DOCUMENT EDGAR
  20. Apr 13, 20268-K EDGAR

The 263 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

32 open-market trades by officers, directors and large owners since October 2021: 18 buys and 14 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jul 23, 2026Matheis DennisDirectorBuy14,430$6.93$100.0KForm 4
Aug 27, 2025Nelson Steven CharlesPresident and CCOBuy40,000$0.53$21.2KForm 4
Nov 12, 2024Nelson Steven CharlesPresident and CCOBuy5,000$0.91$4.5KForm 4
Sep 11, 2024Nelson Steven CharlesPresident and CCOBuy5,000$0.80$4.0KForm 4
Sep 10, 2024Nelson Steven CharlesPresident and CCOBuy5,000$0.84$4.2KForm 4
Sep 9, 2024Nelson Steven CharlesPresident and CCOBuy5,000$0.80$4.0KForm 4
Sep 6, 2024Nelson Steven CharlesPresident and CCOBuy5,000$0.84$4.2KForm 4
Sep 5, 2024Nelson Steven CharlesPresident and CCOBuy5,000$0.82$4.1KForm 4
Aug 27, 2024Raphael ErezChief Executive OfficerBuy5,000$0.88$4.4KForm 4
Aug 23, 2024Nelson Steven CharlesPresident and CCOBuy5,000$0.95$4.8KForm 4
Aug 22, 2024Nelson Steven CharlesPresident and CCOBuy5,000$0.95$4.8KForm 4
Aug 21, 2024Nelson Steven CharlesPresident and CCOBuy5,000$0.93$4.7KForm 4
Aug 21, 2024Raphael ErezChief Executive OfficerBuy5,000$0.95$4.8KForm 4
Aug 20, 2024Raphael ErezChief Executive OfficerBuy5,000$0.93$4.7KForm 4
Aug 20, 2024Nelson Steven CharlesPresident and CCOBuy5,000$0.94$4.7KForm 4
Aug 19, 2024Nelson Steven CharlesPresident and CCOBuy5,000$0.92$4.6KForm 4
Aug 19, 2024Raphael ErezChief Executive OfficerBuy5,000$0.90$4.5KForm 4
Aug 16, 2024Raphael ErezChief Executive OfficerBuy5,000$0.90$4.5KForm 4
Jan 13, 2023Raphael ErezChief Executive OfficerSale1,200$6.21$7.5KForm 4
Dec 21, 2022MCGRATH DENNIS MDirectorSale9,872$3.97$39.2KForm 4

All 32 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Sep 22, 2025Raised $17.5 million in a private offering of equity Form D: 10 investors so far Form D
  2. Jan 7, 2025Raised $6.8 million in a private offering of equity Form D: 18 investors so far Form D
  3. Dec 16, 2024Raised $18.8 million in a private offering of equity Form D: 29 investors so far Form D
  4. Feb 15, 2024Raised $22.4 million in a private offering of equity Form D: 119 investors so far Form D
  5. May 1, 2023Raised $15.4 million in a private offering of equity Form D: 18 investors so far Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Nantahala Capital Management, LLC1,221,382$8.1M0.2%+610,692
Vanguard Capital Management LLC65,675$433.5K0.0%−235
Geode Capital Management, LLC58,035$383.3K0.0%−3,843
BlackRock, Inc.37,796$249.5K0.0%+18,978
Vanguard Fiduciary Trust Co37,387$246.8K0.0%+7,317
Citadel Advisors LLC24,289$160.3K0.0%+3,829
Northern Trust Corp13,237$87.4K0.0%No change
Vanguard Global Advisers, LLC3,321$21.9K0.0%No change
Morgan Stanley3,000$19.8K0.0%+2,000
Osaic Holdings, Inc.1,900$12.5K0.0%+1,899
Royal Bank Of Canada658$4.0K0.0%+210
Trust Co Of Toledo Na /oh/352$2.3K0.0%No change
Fiduciary Financial Advisors159$1.0K0.0%New
UBS Group AG139$9170.0%−15,762
SBI Securities Co., Ltd.69$4550.0%−2
Barclays PLC26$1720.0%New
Steward Partners Investment Advisory, LLC10$660.0%No change
Bnp Paribas Financial Markets9$590.0%No change
Wells Fargo & Company/mn5$330.0%No change
Caitong International Asset Management Co., Ltd2$130.0%+1
Jpmorgan Chase & Co1$70.0%No change

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56